Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries

Abstract

Given the high prevalence of viral hepatitis in the Eastern Mediterranean countries, hepatitis B and C infections are the major causes of hepatocellular carcinoma (HCC) in the region. Most cases are associated with cirrhosis related to hepatitis B or C infection. Environmental, host genetic and viral factors can affect the risk of HCC in patients with hepatitis B and C infection. Understanding the epidemiology and viral risk factors in the region provides the implementation of strategies for prevention and treatment of viral hepatitis. Herein, we reviewed the epidemiology, burden of disease and viral risk factors for HCC.

Keywords

Viral hepatitis / Eastern Mediterranean countries / hepatocellular carcinoma / epidemiology / risk factors / burden

References

[1] Ferlay J,Dikshit R,Mathers C,Parkin DM,Bray F.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012..Int J Cancer2015;136:E359-86

[2] Ozakyol A.Global epidemiology of hepatocellular carcinoma (HCC epidemiology)..J Gastrointest Cancer2017;

[3] Petruzziello A.Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma.Open Virol J2018;12:26-32 PMCID:PMC5842386

[4] El-Serag HB.Epidemiology of viral hepatitis and hepatocellular carcinoma.Gastroenterology2012;142:1264-73.e1 PMCID:PMC3338949

[5] El Serag HB,Petersen NJ.The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.Ann Intern Med2003;139:817-23

[6] Blachier M,Peck-Radosavljevic M,Roudot-Thorav F.The burden of liver disease in Europe: a review of available epidemiological data.J Hepatol2013;58:593-608

[7] Naugler WE,Kim S,Kim K,Karin M.Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.Science2007;317:121-4

[8] Global Burden of Disease Liver Cancer Collaboration.,Abera S,Alam N,Allen C,Alvis-Guzman N,Artaman A,Barac A,Berhane A,Castillo-Rivas J,Choi JY,Dandona L,Dey S,Phuc H,Zaki MS,Fürst T,Hay SI,Jee SH,Khader Y,Kumar A,Larson H,Lunevicius R,McAlinden C,Mendoza W,Moradi-Lakeh M,Nguyen Q,Ogbo F,Pereira DM,Qorbani M,Roshandel G,Sanabria J,Satpathy M,Sepanlou S,Shore H,Mengistu DT,Tran B,Vlassov V,Vos T,Weiderpass E,Yonemoto N,Yu C,Zhu L,Naghavi M.The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015.JAMA Oncol2017;3:1683-91

[9] El-Zayadi AR,Barakat EM,Shawky S,Selim O.Hepatocellular carcinoma in Egypt: a single center study over a decade.World J Gastroenterol2005;11:5193-8 PMCID:PMC4320394

[10] Rahman El-Zayadi A,Shawky S,Selim OE.Prevalence and epidemiological features of hepatocellular carcinoma in Egypt-a single center experience.Hepatol Res2001;19:170-9

[11] Abd-Elsalam S,Soliman H,Elkhalawany W,Hawash N,Badawi R,Khalil HS.Epidemiology of liver cancer in Nile delta over a decade: a single-center study.South Asian J Cancer2018;7:24-6 PMCID:PMC5865090

[12] Alswat KA,Altuwaijri M,Almadi M,Abdo AA.Clinical characteristics of patients with hepatocellular carcinoma in a middle eastern population.Hepat Mon2013;13:e7612 PMCID:PMC3732662

[13] Franceschi S,Polesel J,Crispo A,Casarin P,TommasI LG,Trepo C,Talamini R.Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy.Cancer Epidemiol Biomark Prev2006;15:683-9

[14] Ganem D.Hepatitis B virus infection--natural history and clinical consequences.N Engl J Med2004;350:1118-29

[15] Yang JD,Coelho R,Benson JT,Therneau TM,Roberts LR.Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma.Clin Gastroenterol Hepatol2011;9:64-70 PMCID:PMC3951426

[16] Matsubara K.Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis.Mol Biol Med1990;7:243-60

[17] Mason WS,Litwin S,Peri S,Hong ML,Quaglia A,Kennedy PT.HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant.Gastroenterology2016;151:986-98.e4

[18] Ringelhan M,Protzer U.The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.J. Pathol2015;235:355-67

[19] Ringelhan M,Protzer U.Viral hepatitis and liver cancer.Philos Trans R Soc Lond B Biol Sci2017;372:20160274 PMCID:PMC5597741

[20] Chen CJ,Su J,You SL,Huang GT.Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.JAMA2006;295:65-73

[21] Wong VW,Mo F,Loong HH,Lui YY,Sung JJ,Chan HL.Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.J Clin Oncol2010;28:1660-5

[22] Yuen MF,Fong DY,Wong DK,But DY,Wong BC,Lai CL.Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.J Hepatol2009;50:80-8

[23] Liu CJ,Chen PJ,Huang WL,Chen DS.Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.J Infect Dis2006;193:1258-65

[24] Yang HI,Liaw YF,Sun CA,Hsiao CK,Chen DS,Taiwan Community-Based Cancer Screening Project Group..Hepatitis B e antigen and the risk of hepatocellular carcinoma.N Eng J Med2002;347:168-74

[25] Cho JY,Sohn W,Gwak GY,Lee JH,Paik SW.Chronic hepatitis B patients treated with oral antiviral therapy retain a higher risk for HCC compared to inactive stage patients.Gut2014;63:1943-50

[26] Sánchez-Tapias JM,Mas A,Rodés J.Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients.Gastroenterology2002;123:1848-56

[27] Sumi H,Seki N,Imazeki F,Kanda T,Kato M.Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease.Hepatology2003;37:19-26

[28] Yu MW,Chen PJ,Lin CL,Shih WL,Chen DS.Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.J Natl Cancer Inst2005;97:265-72

[29] Tozun N,Cakaloglu Y,Karasu Z,Kaymakoglu S.Seroprevalance of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study.Clin Microbiol Infect2015;21:1020-6

[30] Aghakhani A,Zamani N,Banifazl M,Sofian M,Irani N,Akbari HMH,Ramezani A.Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma.Int J Infect Dis2009;13:685-9

[31] Baig S,Ahmed W,Arif A.The association of complex liver disorders with HBV genotypes prevalent in Pakistan.Virol J2007;4:128 PMCID:PMC2212638

[32] Abdo AA,Sanai FM,Al-Swat K,Al-Dukhayil M,Al-Faleh FZ.Hepatitis B genotypes: relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia.World J Gastroenterol2006;12:7019-24 PMCID:PMC4087347

[33] Amini-Bavil-Olyaee S,Adeli A,Abachi M,Mahboudi F.Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran.J Med Virol2005;76:318-26

[34] Amini-Bavil-Olyaee S,Mahboudi F,Adeli A,Azizi M.Genotype characterization and phylogenetic analysis of hepatitis B virus isolates from Iranian patients.J Med Virol2005;75:227-34

[35] Pourshams A,Monavvari A,Mohamadkhani A,Seddigghi N,Sotoudeh M.Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors.J Gastroenterol Hepatol2005;20:229-33

[36] Jahani MR,Mahmoodi M.Hepatitis B carriers in large vehicle drivers of Iran.Vaccine2003;21:1948-51

[37] Uzunalimoglu O,Cetinkaya H,Sahin T,Tankurt E,ozenirler S,Tozun N,Okten A.Risk factors for hepatocellular carcinoma in Turkey.Dig Dis Sci2001;46:1022-8

[38] Qirbi N.Epidemiology of hepatitis B virus infection in the Middle East.East Mediterr Health J2001;7:1034-45

[39] Allison RD,Al Awaidy S,Alexander JP.Hepatitis B control among children in the Eastern Mediterranean region of the World Health Organization.Vaccine2016;534:2403-9

[40] Schweitzer A,Mikolajczyk RT,Ott JJ.Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.Lancet2015;386:1546-55

[41] Goldstein ST,Hadler SC,Mast EE.A mathematical model to estimate global hepatitis B disease burden and vaccination impact.Int J Epidemiology2005;34:1329-39

[42] Alavian SM.Relative importance of hepatitis B and C viruses in hepatocellular carcinoma in EMRO countries and the Middle East: a systematic review.Hepat Mon2016;16:e35106 PMCID:PMC4875504

[43] Chang MH,Chen CJ,Lee CM,Chu HC,Yang SS,Chen DS.Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.J Natl Cancer Inst2009;101:1348-55

[44] Mohd Hanafiah K,Flaxman AD.Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.Hepatology2013;57:1333-42

[45] Petruzziello A,Loquercio G,Cacciapuoti C.Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes.World J Gastroenterol2016;22:7824-40 PMCID:PMC5016383

[46] Bruno S,Maisonneuve P,Silini E.Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study.Hepatology2007;46:1350-6

[47] Kanwal F,Ilyas J,El-Serag H.HCV Genotype 3 is associated with an increased risk of cirrhosis and hepatocellular carcinoma in a national samples of US Veterans with HCV.Hepatology2014;60:98-105 PMCID:PMC4689301

[48] Petruzziello A,Loquercio G,Piccirillo M,Azzaro R,Botti G.Hepatitis C Virus (HCV) genotypes distribution among hepatocellular carcinoma patients in Southern Italy: a three year retrospective study.Infect Agent Cancer2017;12:52

[49] Bostan N.An overview about hepatitis C: a devastating virus.Crit Rev Microbiol2010;36:91-133

[50] Raimondi S,Mondelli MU.Hepatitis C virus genotype Ib is a risk factor for hepatocellular carcinoma development: a meta-analysis.J Hepatol2009;50:1142-54

[51] Lok AS,Morgan TR,Sterling RK,Everson GT,Lee WM,Dienstag JL,Morishima C.Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.Gastroenterology2009;136:138-48 PMCID:PMC3749922

[52] Mahale P,Kramer JR,Li R,Engels EA.Hepatitis C virus infection and the risk of cancer among elderly US adults: a registry-based case-control study.Cancer2017;123:1202-11

[53] The growing threats of hepatitis B and C in the Eastern Mediterranean Region: a call for action. Technical paper presented at the 56th Regional Committee for the Eastern Mediterranean, August 2009. Avaiable from: http://applications.emro.who.int/docs/EM_RC56_3_en.pdf. [Last accessed on 22 Jun 2018]

[54] Mohamed MK,El-Hosiyny M,Hassan A,Anwar M,Rekacewicz C,Abdel-Hamid M,Fontanet A.HCV-related morbidity in a rural community of Egypt.J Med Virol2006;78:1185-9

[55] El-Raziky,Esmat G,El-Koofy N,Mansour S,Abdel hamid M.Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children.World J of Gastroenterol2007;13:1828-32 PMCID:PMC4149961

[56] El-Nanawy AA,Soliman AT,Demian RS.Prevalence of hepatitis-C antibody seropositivity in healthy Egyptian children and four high risk groups.J Trop Pediatrics1995;41:341-3

[57] Jafri W,Yakoob J,Tirmizi SF,Akhtar S,Shah HA.Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan.BMC Infect Dis2006;6:101 PMCID:PMC1539007

[58] Ramia S.Distribution of hepatitis C virus genotypes in the Middle East.Int J Infect Dis2006;10:272-7

[59] Sievert W,Razavi HA,Ahmed EA,Amarapurkar D,Dou X,Elshazly M,Guan R,Koike K,McCaughan G,Monis A,Piratvisuth T,Sharara AI,Sood A,Wallace C,Negro F.A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.Liver Int2011;31:61-80

[60] Bdour S.Hepatitis C virus infection in Jordanian hemodialysis units: serological diagnosis and genotyping.J Med Microbiol2002;51:700-4

[61] Shemer-Avni Y,Kemper O,Yaari A,Margalith M.Hepatitis C virus infection and genotypes in Southern Israel and the Gaza Strip.J Med Virol1998;56:230-3

[62] Kabakçı Alagöz G,Karataylı E,Keskin O,Cınar K,Yurdaydın C.Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: performance of phylogenetic analysis of the NS5B, E1, and 5'UTR regions in genotyping efficiency.Turk J Gastroenterol2014;25:405-10

[63] Samimi-Rad K,Malekzadeh R,Magnius L.Molecular epidemiology of hepatitis C virus in Iran is reflected by phylogenetic analysis of NS5B region.J Med Virol2004;74:246-52

[64] Webster DP,Dusheiko GM.Hepatitis C.Lancet2015;385:1124-35

[65] Chung RT.Curing chronic hepatitis C-the arc of a medical triumph.N Engl J Med2014;370:1576-8

[66] Edlin BR.Access to treatment for hepatitis C virus infection: time to put patients first.Lancet Infect Dis2016;16:e196-201

[67] Thomas DL.Global control of hepatitis C: where challenge meets opportunity.Nat Med2013;9:850-8 PMCID:PMC4937625

[68] Denniston MM,McQuillan GM.Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008.Hepatology2012;55:1652-61 PMCID:PMC4586034

[69] Alazawi W,Dearden J.Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.Aliment Pharmacol Ther2010;32:344-55

[70] Waked I,El-Sayed M,Razavi H,Yosry A.The current and future disease burden of chronic hepatitis C virus infection in Egypt.Arab J Gastroenterol2014;15:45-52

[71] Estes C,Abdel-Razek W,Abuzeid M,Osman W,Zaghla H.Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies.Aliment Pharmacol Ther2015;42:696-706 PMCID:PMC5034818

[72] Ziada DH,Soliman H,Salama M,Selim A,Elsabagh HM.Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: a single center study.J Egypt Natl Canc Inst2016;28:257-62

[73] Stroffolini T,Rapicetta M,Filippini P,Petruzziello A,Sarrecchia B.Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.Hepatogastroenterology1992;39:62-5

[74] Sagnelli E,Rapicetta M,Petruzziello A,Chionne P,Filippini P.Interaction between HDV and HBV infection in HBsAg-chronic carriers.Infection1991;19:155-8

[75] Husa P,Nemecek V.Hepatitis D.Acta Virol2005;49:219-25

[76] Değertekin H,Yakut M.The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies.Turk J Gastroenterol2006;17:25-34

[77] Toukan AU,Abu-Laban SA,Kamal MF,Krawczynski K,Maynard JE.The epidemiology and clinical outcome of hepatitis D virus (delta) infection in Jordan.Hepatology1987;7:1340-5

[78] Fattovich G,Schalm SW,Sanchez-Tapias J,Christensen E,Degos F.Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis..Hepatology1995;21:77-82

[79] Fattovich G,Christensen E,Zagni I,Schalm SW.Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)..Gut2000;46:420-6 PMCID:PMC1727859

[80] Abbas Z,Abbas S.Hepatitis D and hepatocellular carcinoma.World J Hepatol2015;7:777-86 PMCID:PMC4404383

[81] Abbas Z,Salih M.Interferon alpha for chronic hepatitis D.Cochrane Database Syst Rev2011;(12):CD006002

[82] Chang MH.Hepatitis B virus and cancer prevention.Recent Results Cancer Res2011;188:75-84